Turnstone Biologics Corp. Common Stock Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
2021
-66M
-55M
3M
4M
5M
-18M
-17M
1M
77M
0M
0 %
0M
0M
-1M
18M
-17M
35M
-67M
-71M
-31M
4M
6M
0M
-58M
-15M
5M
-3M
0M
-0 %
0M
0M
-3M
35M
-89M
124M
-76M
-46M
33M
1M
3M
1M
-86M
-3M
3M
80M
0M
0 %
0M
0M
-3M
124M
31M
93M
-49M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
-16M
-16M
1M
1M
-1M
0M
-5M
0M
0M
0M
-0 %
0M
0M
0M
18M
-21M
39M
-16M
-19M
-17M
1M
1M
-1M
-4M
-42M
0M
78M
0M
-0 %
0M
0M
78M
39M
17M
22M
-19M
-15M
-21M
1M
1M
0M
5M
3M
0M
0M
0M
-0 %
0M
0M
0M
22M
-12M
34M
-15M
-17M
0M
1M
1M
0M
-19M
17M
1M
-1M
0M
0 %
0M
0M
-1M
34M
-1M
35M
-18M
-20M
-14M
1M
2M
0M
-9M
6M
0M
0M
0M
-0 %
0M
0M
6M
35M
-14M
49M
-20M
-12M
-16M
1M
1M
0M
-4M
-17M
2M
-3M
0M
-0 %
0M
0M
-17M
49M
-32M
81M
-14M
-23M
12M
1M
2M
0M
-39M
-3M
2M
0M
0M
0 %
0M
0M
-3M
81M
-26M
107M
-25M
-16M
-13M
1M
1M
0M
-6M
0M
1M
0M
0M
-0 %
0M
0M
-1M
107M
-17M
124M
-17M